fbpx
The Myeloma Crowd Logo
  • Home
  • About
    • Myeloma Crowd Newsroom
  • Learn
    • HealthTree University
    • Myeloma 101
      • What is Multiple Myeloma?
      • Signs and Symptoms of Multiple Myeloma
      • What are the Types of Multiple Myeloma?
      • How is Multiple Myeloma Diagnosed?
      • What is the Average Prognosis for Survival?
      • What are the Stages of Multiple Myeloma?
      • What is the Multiple Myeloma Survival Rate?
    • Myeloma Crowd Radio Episodes
    • Myeloma News
    • Life With Myeloma
    • Myeloma Clinical Trials
    • Myeloma Crowd Round Tables
    • MCRI
    • Deciphering My Lab Results
    • MCTV
  • Events
    • Upcoming Myeloma Crowd Roundtables
    • Muscles for Myeloma
    • Myeloma Meetups
  • Research
    • HealthTree
    • MCRI: Targeting High-Risk Myeloma
    • MCRI: Optimizing Myeloma Care
    • Clinical Trial FAQs
  • Find
    • Find a Myeloma Coach
    • Find a Myeloma Specialist
    • Find a Myeloma Clinical Trial
    • Find Financial & Helpful Resources
  • Connect
    • Newsletter
  • Shop
    • Myeloma Crowd Wish Charm on ericasara Designs
    • Myeloma Crowd Bravelets Jewelry
  • Donate
  • Home
  • About
    • Myeloma Crowd Newsroom
  • Learn
    • HealthTree University
    • Myeloma 101
      • What is Multiple Myeloma?
      • Signs and Symptoms of Multiple Myeloma
      • What are the Types of Multiple Myeloma?
      • How is Multiple Myeloma Diagnosed?
      • What is the Average Prognosis for Survival?
      • What are the Stages of Multiple Myeloma?
      • What is the Multiple Myeloma Survival Rate?
    • Myeloma Crowd Radio Episodes
    • Myeloma News
    • Life With Myeloma
    • Myeloma Clinical Trials
    • Myeloma Crowd Round Tables
    • MCRI
    • Deciphering My Lab Results
    • MCTV
  • Events
    • Upcoming Myeloma Crowd Roundtables
    • Muscles for Myeloma
    • Myeloma Meetups
  • Research
    • HealthTree
    • MCRI: Targeting High-Risk Myeloma
    • MCRI: Optimizing Myeloma Care
    • Clinical Trial FAQs
  • Find
    • Find a Myeloma Coach
    • Find a Myeloma Specialist
    • Find a Myeloma Clinical Trial
    • Find Financial & Helpful Resources
  • Connect
    • Newsletter
  • Shop
    • Myeloma Crowd Wish Charm on ericasara Designs
    • Myeloma Crowd Bravelets Jewelry
  • Donate
  • Better Outcomes Through Education.

EXPLORE BY CATEGORY

Myeloma 101
MC Radio
Myeloma News
Life With Myeloma
Clinical Trials
MC Round Tables
MCRI
MCTV
HealthTree University

Multiple Myeloma News

Dr. Sigurdur Kristinsson’s #ASH19 Top Abstracts, On Early Disease Detection and Treatment

December 2, 2019

In recent years there has been a movement to focus on attempts to detect myeloma early, and determine when to treat to prevent debilitating organ destruction.  The infamous multiple myeloma organ damage is referred to as CRAB (High Calcium, Renal damage, Anemia, and Bone Destruction).   My first thought is CRAB is not descriptive enough[...]

Read More
early disease detection

Multiple Myeloma News

One Week from Giving Tuesday – The Largest Giving Day of the Year!

November 26, 2019

  The holiday season is just around the corner, and we invite you to kick it off with us one week from today on Giving Tuesday (Dec 3)! Giving Tuesday is a global day of giving back. On the Tuesday following Thanksgiving, you’ll have the chance to join people around the world and support a[...]

Read More

Multiple Myeloma News

Tri-Specific Antibodies and the Fight Against Multiple Myeloma

November 25, 2019

Those of us who already have Darzalex as part of our multiple myeloma treatment will unquestionably be familiar with the term ‘monoclonal antibody’ (mAb). The monoclonals are antibodies that target one specific protein (CD38) that tends to be amply found on the surface of myeloma cells. The rapid growth of the inclusion of Darzalex as[...]

Read More
antibodies

Multiple Myeloma News

Dr. Ola Landgren’s Favorite #ASH19 Myeloma Abstracts and WHY He Chose Them!

November 22, 2019

The American Society of Hematology 2019 (ASH) meeting will be held the first week of December. It is the largest meeting in the world on blood cancers. It is very important to know why these outstanding myeloma specialists have chosen these abstracts as the most significant.  The last blog post from Myeloma Crowd’s #ASH19 coverage[...]

Read More
ASH

Multiple Myeloma News

Levofloxacin Before Stem Cell Transplant Reduces Infections and Death in Newly Diagnosed Myeloma

November 18, 2019

  Using the antibiotic levofloxacin prior to stem cell transplant reduces death in newly diagnosed myeloma patients, according to a new study by UK myeloma research collaborators and Myeloma UK.   Infection is the leading cause of death for myeloma patients because the myeloma critically depresses the immune system. In the United Kingdom, there are[...]

Read More

Multiple Myeloma News

Ninlaro Extends Survival as Maintenance Therapy for Transplant Ineligible Patients

November 14, 2019

Phase III results of a recent study (TOURMALINE-MM4) show that Ninlaro (ixazomib) can prolong survival when used as maintenance therapy for multiple myeloma patients who are not fit enough to receive a stem cell transplant. Ninlaro is in a class of drugs called proteasome inhibitors. Revlimid (lenalomide), an immumomodulator, is commonly used in today’s myeloma[...]

Read More
ninlaro

Multiple Myeloma News

The 2019 ASH Guide! Myeloma Specialists Choose The Best Myeloma Abstracts For #ASH19

November 14, 2019

Myeloma Crowd has made it a priority to help the ASH participants interested in multiple myeloma to find the best and most relevant myeloma abstracts from the total of over 1000 myeloma abstracts listed. Each year over 30,000 Doctors, Researchers, Patient Advocates, and Patients attend the ASH conference, and to say it is confusing and overwhelming[...]

Read More
ASH

Multiple Myeloma News

Taking Your Meds – The Challenges of Oral Drug Compliance in Cancer Care

November 14, 2019

The Journal of Oncology Pharmacy Practice published a research paper recently that was quite an eye opener about how well patients with a new diagnosis of a hematological cancer comply with their oral drug regimens. Refills of all oral drugs (oncolytics and non-oncolytics) were tracked for a large number of patients over a period of[...]

Read More
meds

Multiple Myeloma News

Myeloma Clinical Trials: Rafael Fonseca, MD and Brian McMahon, Founder of SparkCures

November 14, 2019

Dr. Rafael Fonseca from the Mayo Clinic recently had a conversation Brian McMahon, founder and CEO of SparkCures, about myeloma clinical trials. You can view their interview below, where they discuss the importance of clinical trials, how to search for them, and how to discuss them with your doctors. If you’re interested in finding out[...]

Read More

Multiple Myeloma News

Dr. Rajkumar’s Guide to the Best Myeloma Abstracts for ASH 2019

November 12, 2019

Each year over 30,000 doctors, researchers, patient advocates, and patients attend the American Society of Hematology (ASH) conference. To say it is confusing and overwhelming would be an understatement. There are more than 1925 Oral Abstracts and 4039 Poster Abstracts! How does anyone navigate through the maze to make the best use of their time?[...]

Read More
ash
Load more articles >

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors:

  • facebook
  • twitter
  • youtube
  • youtube
App store
  • About
  • Learn
  • Events
  • Research
  • Find
  • Connect
  • Newsletter
  • Newsroom
  • Terms of Use and Privacy Policy
  • Donations

Copyright © 2019 CrowdCare Foundation. All Rights Reserved.

The Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

Near me
40 miles